CA2004695C - Phospholipid nucleosides - Google Patents

Phospholipid nucleosides

Info

Publication number
CA2004695C
CA2004695C CA002004695A CA2004695A CA2004695C CA 2004695 C CA2004695 C CA 2004695C CA 002004695 A CA002004695 A CA 002004695A CA 2004695 A CA2004695 A CA 2004695A CA 2004695 C CA2004695 C CA 2004695C
Authority
CA
Canada
Prior art keywords
compound
formula
compounds
nucleosides
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002004695A
Other languages
English (en)
French (fr)
Other versions
CA2004695A1 (en
Inventor
Rosanne Bonjouklian
Gerald Burr Grindey
Larry Wayne Hertel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CA2004695A1 publication Critical patent/CA2004695A1/en
Application granted granted Critical
Publication of CA2004695C publication Critical patent/CA2004695C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002004695A 1988-12-12 1989-12-06 Phospholipid nucleosides Expired - Fee Related CA2004695C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28276688A 1988-12-12 1988-12-12
US07/282,766 1988-12-12

Publications (2)

Publication Number Publication Date
CA2004695A1 CA2004695A1 (en) 1990-06-12
CA2004695C true CA2004695C (en) 1999-08-10

Family

ID=23083035

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002004695A Expired - Fee Related CA2004695C (en) 1988-12-12 1989-12-06 Phospholipid nucleosides

Country Status (5)

Country Link
EP (1) EP0376518B1 (ja)
JP (1) JP2817972B2 (ja)
CA (1) CA2004695C (ja)
DE (1) DE68924970T2 (ja)
ES (1) ES2081308T3 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563257A (en) * 1990-08-20 1996-10-08 Boehringer Mannheim Gmbh Phospholipid derivatives of nucleosides
US5484911A (en) * 1993-04-01 1996-01-16 Health Research, Inc. Nucleoside 5'-diphosphate conjugates of ether lipids
JP2001518931A (ja) * 1997-03-24 2001-10-16 イーライ・リリー・アンド・カンパニー ジフルオロヌクレオシドホスホン酸とその誘導体
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
CA2472581C (en) 2002-01-15 2012-06-26 Trustees Of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
EP1464708A1 (en) * 2003-04-03 2004-10-06 Pro. Bio. Sint. S.p.A. A process for the preparation of fludarabine phosphate from 2-fluoroadenine
GB0505781D0 (en) * 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
CA2670099A1 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
TW200942231A (en) 2008-01-11 2009-10-16 Reata Pharmaceuticals Inc Synthetic triterpenoids and methods of use in the treatment of disease
JP5564490B2 (ja) 2008-04-18 2014-07-30 リアタ ファーマシューティカルズ インコーポレイテッド 抗炎症性ファルマコアを含む化合物および使用法
CN104250280A (zh) 2008-04-18 2014-12-31 里亚塔医药公司 抗氧化剂炎症调节剂:c-17同系化齐墩果酸衍生物
TW201004627A (en) 2008-04-18 2010-02-01 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: novel derivatives of oleanolic acid
NZ588710A (en) 2008-04-18 2012-12-21 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
WO2009129545A1 (en) 2008-04-18 2009-10-22 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
US9937128B2 (en) 2009-08-03 2018-04-10 The University Of North Carolina At Chapel Hill Liposomes comprising a calcium phosphate-containing precipitate
JP6042527B2 (ja) 2012-04-04 2016-12-14 ハロザイム インコーポレイテッド 抗ヒアルロナン剤と腫瘍標的タキサンの組み合わせ治療
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
CN110831605A (zh) 2017-04-26 2020-02-21 托马斯·I.·卡尔曼 多靶标的核苷衍生物
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
WO2020041051A1 (en) * 2018-08-20 2020-02-27 Cure Biopharma Inc. Gemcitabine prodrugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184365B1 (en) * 1984-12-04 1993-08-04 Eli Lilly And Company Improvements in the treatment of tumors in mammals
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
DE3778626D1 (de) * 1986-09-27 1992-06-04 Toyo Jozo Kk Nukleosid-phospholipid-konjugat.

Also Published As

Publication number Publication date
CA2004695A1 (en) 1990-06-12
JPH02202896A (ja) 1990-08-10
EP0376518B1 (en) 1995-11-29
JP2817972B2 (ja) 1998-10-30
DE68924970D1 (de) 1996-01-11
DE68924970T2 (de) 1996-05-15
EP0376518A1 (en) 1990-07-04
ES2081308T3 (es) 1996-03-01

Similar Documents

Publication Publication Date Title
CA2004695C (en) Phospholipid nucleosides
EP0269574B1 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
DE68906183T2 (de) 2'-desoxy-5-fluoruridinderivate.
JPS6354719B2 (ja)
HU211960A9 (en) Epipodophyllotoxinglucosid-4'-phosphat-derivatives
US4542021A (en) Antitumor compositions for non-injection administration
HU221808B1 (hu) Spikamicinszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
JPH03112933A (ja) 抗腫瘍剤
US3290285A (en) Method of production of 5'-guanylic acid
US3404144A (en) 1-beta-d-arabinofuranosyl-5-fluorocytosine compounds
JPS61152694A (ja) 新規な５−フルオロ−２′−デオキシウリジン−５′−ホスフエ−ト誘導体およびその塩
US5302587A (en) Platinum (II) complex and agent for treating malignant tumor
CA1234834A (en) Phospholipids
EP2542560B1 (en) Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
US3751408A (en) Imidazole-ribosyl cyclophosphate compounds and therapeutic compositions
CA1173437A (en) Ester derivatives of alkoxybenzoyldeoxyfluorouridine
WO1991006555A1 (en) Nucleoside derivative
JPS63135399A (ja) サイクリツクａｍｐ誘導体
JPS6054960B2 (ja) 抗しゆよう性セプタシジン類似体
CA2085520C (en) Stable hexahydrate of etoposide 4'-phosphate disodium salt
JP3813996B2 (ja) アスコルビン酸−アルブチン結合体またはその塩、ならびにその製造方法
US2479148A (en) S-crotyl-s-phenylbarbituric
KR0170079B1 (ko) 아시클릭 뉴클레오시드의 인지질 유도체 및 이의 제조방법
IE49924B1 (en) New inorganocyclic compounds usable as medicaments and a process for their preparation
JPH0613546B2 (ja) 核酸誘導体および該誘導体を有効成分とする制癌剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed